Antimony Resources Limited Overview
| Field | Detail | Source |
|---|---|---|
| Current legal name | Antimony Resources Limited | SmallCaps, Sep 2026; Market Index |
| Current ASX ticker | ANT (trading from 21 September 2026) | SmallCaps, Sep 2026 |
| Former names (most recent first) | EV Resources Limited (EVR, Dec 2021–Sep 2026); Jadar Resources Limited (JDR, Dec 2019–Dec 2021); Jadar Lithium Limited (JDR, ~Jan 2018–Dec 2019); South East Asia Resources Limited (SXI, to Jan 2018); Victory West Metal Limited (VWM, to Dec 2012); Victory West Moly Limited (VWM, to Apr 2011); Richfield Group Limited (RCH, to Feb 2009); Worldwide Technology Group Limited (WWT, to Dec 2002); Oka Motor Company Limited (OKA, to Dec 1999) | Market Index former-name register; Business News |
| ABN | 66 009 144 503 | H1 FY2026 Interim Report |
| Founding / incorporation year | 1,985 | MarketBeat, StockAnalysis company profiles |
| Incorporation jurisdiction | Australia (domiciled in Australia; state of registration not confirmed in sources reviewed) | H1 FY2026 Interim Report, Note 1(a) |
| ASX listing date | 7 December 1994 | Market Index |
| Headquarters / registered office | 311–313 Hay Street, Subiaco, Western Australia 6008; Tel +61 8 6489 0600 | H1 FY2026 Interim Report; 14 Sep 2026 ASX release |
| Other listings | Frankfurt (R1E.F), Berlin (R1E.B), Stuttgart (R1E.SG) per company corporate directory; StockAnalysis lists Frankfurt code as R1EA (discrepancy noted) | H1 FY2026 Interim Report; StockAnalysis |
| ISIN / CUSIP | Not publicly verified in this research (ISIN may have been reissued on the 2026 consolidation/name change); no CUSIP (not US-listed) | — |
| Fiscal year end | 30 June | H1 FY2026 Interim Report |
| Employees | Not publicly disclosed (company operates with a small executive team, contractors and Mexican site staff) | — |
| Auditor | Grant Thornton Audit Pty Ltd, Perth (review partner B P Steedman) | H1 FY2026 Interim Report |
| Share registry | Automic (formerly Advanced Share Registry per older data) | H1 FY2026 Interim Report; Market Index |
| Banker | National Australia Bank | H1 FY2026 Interim Report |
| Website | www.evresources.com.au (EV-era domain); legacy www.jadar.com.au no longer the corporate site | 14 Sep 2026 ASX release |
| Market capitalisation (current) | Approx. A$13.4m–A$14.0m (October 2026) | Simply Wall St (ASX:ANT page) |
| Last verified share price | A$0.041 (close 25 Sep 2026, post 10:1 consolidation) | StockAnalysis (ASX:ANT) |
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Employees (headcount) — not publicly disclosed | — | — | — |
Headcount is not disclosed in any filing reviewed. The H1 FY2026 segment note records only A$50,000 of "employment" cost in the corporate segment for the half, indicating that most personnel costs run through consulting, director fees and share-based payments rather than payroll.
Antimony Resources Limited is a Perth-headquartered micro-cap that has spent four decades cycling through business identities — motor vehicles, technology, molybdenum, Serbian lithium, Peruvian gold and Americas copper — before concentrating, from 2025, on antimony. Its current thesis is a "processing-first" route to cash flow: a leased-with-option 150 tonne-per-day mill at Tecomatlán, Puebla, Mexico, refurbished for flotation and gravity recovery and fed initially by third-party high-grade ore under a binding five-year supply agreement (Chinantla) and additional regional feed (Vinatas). Behind the plant sits the 70%-owned Los Lirios antimony project in Oaxaca, where a maiden JORC resource is targeted for Q4 CY2026, and two 100%-owned Nevada antimony claim groups (Dollar and Milton) giving US critical-minerals optionality. The company is pre-revenue, carries a going-concern material uncertainty, and funds itself through frequent small equity raises. It offers high-risk, binary exposure to Western antimony supply-chain security.
What the company does
Antimony Resources is a mineral exploration and development company. Its stated principal activity in the H1 FY2026 Interim Report is mineral exploration and development aimed at addressing the structural deficit in global antimony supply, via projects in Mexico and the United States. In practical terms, the business in late 2026 comprises three linked activities:
-
Toll-style / ore-purchase processing (Tecomatlán, Mexico). The company controls, via a 12-month lease with a US$1.8 million purchase option (subsequently restructured to a milestone-based structure with a reported US$10,000 upfront payment), a 150 tpd processing plant with crushing, three ball mills and flotation cells. It is completing a production-capable "proof-of-concept" campaign on a 200-tonne high-grade ore parcel and intends to buy third-party ore from regional artisanal and small-scale miners, produce antimony concentrate, and sell it to traders or smelters.
-
Exploration and resource definition (Los Lirios, Mexico; Dollar and Milton, Nevada; residual Peru/Austria/Australia interests). Los Lirios (70% via joint-venture company Exploraciones Mineras los Lirios) is intended as a future proprietary feed source.
-
Portfolio recycling. Over 2025 the company sold non-core assets (La Cienega, Coyote Creek, Khartoum, Yanamina) for cash, shares and royalties, retaining NSR royalties on several.
Business and revenue model
| Revenue stream | Status (Oct 2026) | Model | Disclosure |
|---|---|---|---|
| Antimony concentrate sales | Pre-revenue; first concentrate targeted 2H CY2026 | Product sales; benchmark-linked pricing contemplated in ore-supply and offtake terms | 6 Aug 2026 and 14 Sep 2026 ASX releases |
| Third-party ore processing margin | Pre-revenue | Purchase ore at benchmark-linked prices, process, sell concentrate (merchant processing) | 6 Aug 2026 ASX release |
| Royalties | Non-producing | 1% NSR (Khartoum), 2% NSR (La Cienega), retained royalty (Coyote Creek) | H1 FY2026 Interim Report; news reports |
| Asset sale consideration | Episodic | Cash/share proceeds from divestments (e.g., A$700k Khartoum; US$6m staged Yanamina) | H1 FY2026 Interim Report |
| Interest income | Immaterial | A$4,653 in H1 FY2026 | H1 FY2026 Interim Report |
Product vs service vs subscription vs licensing mix: 100% prospective product (concentrate) revenue; no service, subscription or licensing revenue. Recorded revenue in FY2025 was approximately A$0.02 million (S&P data), essentially interest/other income.
Value-chain position
The company sits in the upstream and midstream of the antimony chain: ore sourcing (own exploration plus third-party purchase) and beneficiation into a concentrate (target grades of roughly 42%–68% Sb demonstrated in testwork). It does not smelt or refine at commercial scale, though it has run small direct-to-smelter test melts producing antimony ingots at a third-party facility in Guadalajara (reported February 2026). Downstream customers would be traders (an MOU with Wogen and XCLR contemplated 100% offtake and up to US$3 million of production-linked funding) and smelters/refiners serving flame-retardant, lead-acid battery, alloy and defence end-markets.
Customer types and end-markets
| Customer type | Status | Notes |
|---|---|---|
| Commodity traders | MOU stage (Wogen/XCLR, non-binding, 2025) | Offtake plus production-linked funding concept |
| Smelters / refiners | Discussions ("several positive discussions" per 14 Sep 2026 release) | No binding offtake disclosed |
| US government-linked programmes | Engagement via MineMaker LLC (2026) | Target agencies cited: US Department of Energy, Department of War, Export-Import Bank |
End-markets ultimately served by antimony: flame retardants (antimony trioxide), lead-acid battery alloys, ammunition and defence materials, glass and ceramics, semiconductors and emerging energy-storage chemistries. Antimony is designated a critical mineral by the US, the EU and Australia (company releases, 2026).
Company's own description vs independent characterisation
Company description (paraphrased from 14 September 2026 ASX release): a critical minerals exploration and development company focused on securing the North American antimony supply chain, rapidly transitioning from diversified explorer to expected near-term producer, building an integrated platform of regional ore supply and processing at Tecomatlán, potential future proprietary feed from Los Lirios, and direct US exposure through Nevada assets.
Independent characterisation: a pre-revenue, cash-constrained micro-cap whose near-term value hinges on proving a small merchant-processing operation in Mexico using third-party ore. The "integrated North American platform" language is aspirational: the Nevada assets are early-stage claim groups with rock-chip results only; Los Lirios has no JORC resource yet (target date has already slipped from Q3 to Q4 CY2026); and the plant is not yet wet-commissioned at full-flowsheet scale. The company's history of repeated strategic pivots and serial name changes is a material governance and credibility consideration for investors.
Strategy
Stated strategy (themes paraphrased from 2025–2026 reports and releases)
-
Secure the North American antimony supply chain — reduce Western reliance on Chinese and Russian supply.
-
Processing-first, low-capex entry — use an existing plant (Tecomatlán) and third-party ore to reach first concentrate and cash flow before major mine capex.
-
Proprietary feed from Los Lirios — define a maiden JORC resource and position Los Lirios as long-term feed.
-
US exposure via Nevada — Dollar and Milton as platform assets for US federal programmes (DoD/"Department of War", DOE, EXIM, Defense Production Act, IRA-related pathways).
-
Portfolio streamlining and capital recycling — sell non-core assets, retain royalties.
Initiatives in the last 24 months
| Initiative | Date | Detail | Status |
|---|---|---|---|
| Los Lirios acquisition (70%) | Jan–Jun 2025 | JV structure with original owners | Completed |
| Wogen / XCLR MOU | Aug–Sep 2025 | 100% offtake concept + up to US$3m production-linked funding | Non-binding |
| Nevada acquisitions | Sep 2025 | Dollar, Milton | Completed |
| Tecomatlán plant | Oct 2025 onward | Lease/option; refurbishment; flotation-led flowsheet adopted Jun 2026 | Commissioning |
| Maiden drilling at Los Lirios | Jan 2026 | 1,500–2,000 m HQ diamond; ~900 m strike tested | Phase 1 complete |
| Direct-to-smelter testing | Feb 2026 | Ingots produced at third-party Guadalajara facility | Test only |
| MineMaker LLC engagement | Q1 2026 | US agency engagement, non-dilutive funding pathways | Ongoing |
| Feedstock network | May–Sep 2026 | Chinantla binding 5-yr supply; 200 t stockpile purchase; Vinatas feed | Executed |
| Capital restructuring | Jul–Sep 2026 | A$1.52m rights issue; 10:1 consolidation; rebrand to Antimony Resources | Completed |
| Sustainability commitment | Oct 2021 | "Jadar Commits to Sustainability" announcement | Historical; no quantified targets |
Management targets / guidance
| Target | Original timing | Latest timing |
|---|---|---|
| First antimony concentrate | 2H CY2026 | 2H CY2026 (maintained, Sep 2026) |
| Tecomatlán "production-ready" | 2H 2026 | Wet commissioning pending (Sep 2026) |
| Full plant operations | — | 10–12 months from Jul 2026 per company update |
| Maiden Los Lirios JORC resource | Q3 CY2026 | Q4 CY2026 |
| Ramp toward 150 tpd nameplate | After proof-of-concept | Not dated |
| Capacity upgrade toward 400 tpd | Phase 1 refurbishment concept | Not dated |
No medium-term financial targets (revenue, EBITDA, unit costs) have been published.
Products & Services
Because the company is pre-revenue, its "portfolio" is a set of assets and planned products. Each is catalogued individually.
Mexico segment
A. Tecomatlán Processing Plant (Puebla, Mexico) — flagship near-term asset
-
Description: existing 150 tpd nameplate mill on private land ~50 km from Los Lirios, historically used to process ore from regional artisanal antimony and precious-metal mines.
-
Equipment: crushers, three ball mills (all refurbished and dry-commissioned by May 2026), flotation cell banks (dry-commissioned 21 Jul 2026; ~90% complete per Sep 2026 interview), Falcon gravity concentrators (two ordered; first pre-paid Feb 2026), transformer and diesel backup generator; national grid ~100 m away (CFE interconnection application lodged May 2026).
-
Tenure: secured October 2025 via 12-month lease with US$1.8m purchase option; later restructured to an option-to-purchase with bulk capital deferred to the back end of permitting and a reported US$10,000 upfront payment (SmallCaps).
-
Planned expansion: Phase 1 low-capex refurbishment with stated ambition to lift capacity to 400 tpd (SmallCaps report on restructured option).
-
Permits: Change of Use of Soil permit granted to plant owner (May 2026); environmental permits reported as secured in the June 2026 quarterly.
-
Status: crushing and screening of ore underway from September 2026; approximately 200 t crushed at an estimated ~12.6% Sb (assays pending) per 25 Sep 2026 interview.
-
Product: antimony (stibnite) concentrate. Testwork: Chinantla ore flotation 81.1% recovery at 42.4% Sb, upgradable to 62.9% Sb; Vinatas ore 78.6% recovery, 58.8% Sb flotation concentrate upgraded to 68.3% Sb by gravity cleaning.
-
Pricing model: benchmark-linked (disclosed in principle; numbers not disclosed).
B. Los Lirios Antimony Project (Oaxaca, Mexico) — 70%
-
Tenure: three to four mining concessions (sources variously cite 1,522 ha, 1,552 ha and 1,652 ha — discrepancy noted) in Zapotitlán Lagunas district, north-west Oaxaca; held via JV company Exploraciones Mineras los Lirios (70% company via subsidiary, 30% original owners).
-
Geology: ≥6 km Lirios Fault Zone; two styles — high-grade vertical feeder structures and sub-horizontal carbonate-replacement (manto) bodies beneath a gypsum cap; Hormiguero breccia (>70 m wide, up to 380 m long).
-
Results: stockpile samples 29.2%, 20.4%, 18.1% Sb; individual peaks to ~63% Sb; channel results to 30.2% Sb (Feb 2026); underground channel samples to 25.2% Sb (Jun 2026); first drill results include 3.05 m at 2.10% Sb from 8.1 m (Lirios 1); Cofradia 2.2 m at 5.20% Sb (Jul 2026).
-
Metallurgy: gravity >70% recovery at 4.45% Sb head grade; up to 90.8% (gravity) and 99.2% (flotation/leach) on deeper sulphide material; no deleterious arsenic or mercury reported.
-
Exploration Target: reported as 1.8–5.0 Mt in the June 2026 quarterly (grade range and basis should be read from the original announcement; Exploration Targets are conceptual and not resources).
-
Next milestone: maiden JORC resource targeted Q4 CY2026 (previously Q3 CY2026).
C. Third-party feedstock contracts (Mexico)
-
Chinantla (Lucero Grupo Minero de Puebla SA de CV): binding five-year ore supply agreement, ~8 km from Tecomatlán (6 Aug 2026); binding purchase of 200 dry tonnes of high-grade stockpile (11 Aug 2026).
-
Vinatas: ore secured as additional feedstock (Sep 2026).
-
Aggregate MOUs reported to cover >50% (50–60%) of nameplate capacity.
USA segment
D. Dollar Antimony Project (Nye County, Nevada) — 100%
-
8 unpatented claims, 160 acres; acquired Sep 2025 for a US$50,000 staking-fee refund plus 2% NSR.
-
Historic adits (>400 ft) and shaft; historical assays to 40.63% Sb; 2025 reconnaissance returned 15.05% Sb, 17.8% Cu and >10,000 ppm Ag; ~12 km from Kinross's Round Mountain mine; proximity to US Army Hawthorne depot cited.
E. Milton Antimony Project (Nye County, Nevada) — 100%
-
18 lode claims; acquired Sep 2025 for A$150,000 cash and A$350,000 in shares.
-
Historical small-scale production >40% Sb; rock chips 9.82% Sb, 24.0% Cu, 434 ppm Ag (Jan 2026).
Peru segment
F. Don Enrique Copper-Silver Project — 100% (from 11 Mar 2026) — 1,800 ha; remaining 50% of Minera Montserrat SAC bought for US$150,000; to be merged with contiguous Estrella group (884 ha, Coripuquio SAC) for ~2,684 ha with an undrilled IP chargeability anomaly.
G.
H.
I.
Europe and Australia
J. Austrian lithium (Weinebene / Eastern Alps) — legacy exploration interests; H1 FY2026 Austria segment cost A$0.458m; E&E carrying value nil at Dec 2025.
K. Royalties — Khartoum (Qld) 1% NSR (Koba Resources); La Cienega (Arizona) 2% NSR (Magnum Mining & Exploration); Coyote Creek (Utah) retained royalty (Trigg Minerals).
L.
Financial Narrative
All annual figures FY2021–FY2025 are from S&P Global Market Intelligence (via StockAnalysis), cross-checked to the FY2025 comparatives in the H1 FY2026 Interim Report where available. EPS from S&P is restated for the September 2026 10:1 consolidation.
Income statement
EBITDA and pre-tax income are not separately disclosed in the source data; given negligible depreciation (A$2,153 in H1 FY2026) and nil tax, EBITDA and pre-tax income approximate operating income and net loss respectively. Gross, operating, EBITDA and net margins are mathematically meaningless (e.g., S&P computes FY2025 operating margin at roughly -34,000%) because revenue is effectively nil. Revenue CAGR: not meaningful.
FY2025 detail (from H1 FY2026 equity statement): loss attributable to members A$6,323,252; total loss A$6,161,467 after NCI; E&E write-off A$4,692,186 — i.e., ~74% of the FY2025 loss was non-cash impairment of legacy projects.
Half-year income statement detail (A$)
Source: H1 FY2026 Interim Report. Basic and diluted loss per share: 0.22 cents (H1 FY2026) vs 0.05 cents (H1 FY2025), pre-consolidation.
Balance sheet
At 31 December 2025 (reviewed): total assets A$6.49m; cash A$3.20m; assets held for sale A$0.92m; E&E A$2.02m; borrowings A$0.46m (director-related Allgreen Holdings loan at 10% p.a., repaid in full 17 Feb 2026); total liabilities A$0.92m; net assets A$5.57m; working capital surplus A$3.36m; issued capital A$64.90m; accumulated losses A$59.96m; shares on issue 3,040,003,147; options 473,351,964; performance rights 305,000,000.
Cash flow
H1 FY2026: operating cash flow -A$2.61m (incl. A$1.14m exploration payments); investing -A$0.14m (A$0.33m disposal proceeds offset tenement and exploration payments); financing +A$4.96m (A$5.75m share proceeds less A$0.35m costs and A$0.44m loan repayment); net cash increase A$2.21m.
Ratios (year-end basis, computed from S&P data)
ROIC, net debt/EBITDA, interest coverage, asset turnover and cash conversion cycle are not meaningful for a pre-revenue explorer with negative EBITDA and no sales. Current ratio at 31 Dec 2025 was ~4.6x after the September–December 2025 placements.
Commentary on trends and drivers
Persistent losses funded by equity. Over FY2021–FY2025 cumulative net losses were roughly A$20.3m, while issued capital rose from A$44.7m to A$57.5m, and to A$64.9m by December 2025. The company has never paid a dividend and has no operating cash flow; every strategic phase has been financed through placements, rights issues and share-based consideration. Share count rose from ~712m (FY2021) to ~3.04bn (Dec 2025) before the 10:1 consolidation — a more than fourfold increase in five years.
Impairment-driven loss spikes. FY2023 (-A$5.2m) and FY2025 (-A$6.3m) losses were inflated by write-downs of legacy exploration assets as the company exited lithium and copper projects; FY2025 alone wrote off A$4.7m. The E&E balance fell from A$8.2m (FY2024) to A$3.4m (FY2025) and A$2.0m (Dec 2025), meaning book value now captures little of the antimony strategy.
Liquidity inflection points. Cash peaked at A$4.9m (FY2022) after the Jadar-era raisings, then fell to A$0.4m by FY2024, forcing reliance on a director-related loan (A$1.27m debt at FY2024). The 2025 antimony pivot coincided with renewed investor support (A$5.5m raise Sep 2025), lifting cash to A$3.2m by December 2025. By July 2026, however, the company again needed a rights issue (A$1.52m at a 10:1 consolidation), indicating cash had been substantially consumed by plant refurbishment and drilling.
Share-based remuneration. H1 FY2026 share-based payments of A$2.08m represented ~40% of the half-year loss, driven by 305m performance rights and director share/option grants — material dilution and expense relative to the company's size.
Going concern. Both directors and the auditor flagged a material uncertainty about going concern in the H1 FY2026 report; forecasts indicated additional funding would likely be required within 12 months of March 2026, which materialised in the July 2026 rights issue.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment Overview
| Segment | Contents (as of 31 Dec 2025 and subsequently) |
|---|---|
Corporate | Perth head office, listed-company costs, share-based payments, treasury |
Australia | Residual Australian interests (Khartoum transferred to assets held for sale and sold to Koba Resources; 1% NSR retained); historical Shaw River/Pilbara lithium interests |
Austria | Austrian lithium exploration (Weinebene / Eastern Alps per third-party profiles) |
Peru | Yanamina (held for sale), Don Enrique (100% from Mar 2026), Estrella (Coripuquio SAC), Parag Cu-Mo, Tierra Blanca |
USA | Dollar and Milton antimony projects (Nevada) |
Mexico | Los Lirios (70%), Tecomatlán plant (lease/option), Stibcorp SA operating subsidiary |
Other | Minor other receivables |
Revenue by Segment
| Segment result (AUD Mn) | H1FY2025 | H1FY2026 |
|---|---|---|
Corporate | -0.946 | -3.634 |
Australia | -0.026 | -0.008 |
Austria | -0.014 | -0.458 |
Peru | -0.091 | 0.102 |
USA | 0 | 0 |
Mexico | 0 | -1.156 |
Total | -1.076 | -5.154 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansSegment E&E asset (AUD Mn)
| Segment E&E asset (AUD Mn) | Dec2024 | Dec2025 |
|---|---|---|
Australia | 1.442 | 0.082 |
Austria | 1.361 | 0 |
Peru | 6.228 | 1.442 |
USA | 0 | 0.500 |
Mexico | 0.413 | 0 |
Total | 9.444 | 2.025 |
Segment revenue (AUD Mn)
| Segment revenue (AUD Mn) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
All segments (other income only) | 0 | 0 | 0.02 |
Income Statement and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue incl. other income (AUD Mn) | 0 | 0.02 | 0 | 0 | 0.02 |
Gross profit (AUD Mn) | 0 | 0.02 | 0 | 0 | 0.02 |
Operating income (AUD Mn) | -2.97 | -3.07 | -4.34 | -3.19 | -6.38 |
Net income attributable (AUD Mn) | -3.03 | -2.34 | -5.22 | -3.39 | -6.32 |
EPS basic consolidation-adjusted (AUD) | -0.05 | -0.03 | -0.06 | -0.03 | -0.04 |
Dividends per share (AUD) | 0 | 0 | 0 | 0 | 0 |
Income Statement
| Line item (AUD Mn) | H1FY2025 | H1FY2026 |
|---|---|---|
Interest and other income | 0.007 | 0.005 |
Director fees | -0.274 | -0.235 |
Exploration expenditure impaired | 0 | -1.353 |
Exploration and evaluation expenses | -0.487 | -1.177 |
Share-based payments | 0.217 | -2.082 |
Professional fees | -0.164 | -0.230 |
Loss after tax | -1.076 | -5.154 |
Total comprehensive loss | -0.769 | -5.455 |
Balance Sheet and Share Count (M)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total assets (AUD Mn) | 4.68 | 10.32 | 6.45 | 9.41 | 5.13 |
Cash and equivalents (AUD Mn) | 1.68 | 4.94 | 0.51 | 0.40 | 0.99 |
Short-term debt (AUD Mn) | 0 | 0 | 0 | 1.27 | 0.86 |
Long-term debt (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Net debt (AUD Mn) | -1.68 | -4.94 | -0.51 | 0.87 | -0.13 |
Total equity (AUD Mn) | 4.15 | 9.87 | 5.79 | 6.82 | 2.37 |
Goodwill and intangibles (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Exploration assets in PP&E line (AUD Mn) | 2.36 | 3.42 | 4.81 | 8.21 | 3.46 |
Working capital (AUD Mn) | 1.79 | 4.62 | 0.10 | -1.40 | -1.23 |
Shares outstanding pre-consolidation (M) | 712 | 926 | 936 | 1,321 | 1,986 |
Cash Flow
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Operating cash flow (AUD Mn) | -1.69 | -2.33 | -1.93 | -2.61 | -0.98 |
Capex incl. capitalised exploration (AUD Mn) | -0.87 | -1.70 | -2.49 | -3.38 | -1.14 |
Free cash flow (AUD Mn) | -2.56 | -4.03 | -4.43 | -5.98 | -2.12 |
Dividends paid (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Buybacks (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
ROE year-end equity (%) | -73.0 | -23.7 | -90.2 | -49.7 | -266.7 |
ROA year-end assets (%) | -64.7 | -22.7 | -80.9 | -36.0 | -123.2 |
Current ratio (x) | 4.38 | 11.52 | 1.14 | 0.32 | 0.55 |
Debt to equity (x) | 0 | 0 | 0 | 0.19 | 0.36 |
Geographic revenue (AUD Mn)
| Geographic revenue (AUD Mn) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Australia (incl. corporate) | 0 | 0 | 0.02 |
Peru | 0 | 0 | 0 |
Austria | 0 | 0 | 0 |
USA | 0 | 0 | 0 |
Mexico | 0 | 0 | 0 |
Share Price & Returns
| Period | Return (%) | Source |
|---|---|---|
1 year to Oct 2026 | -71.4 | Simply Wall St (ASX:ANT) |
3 years to Oct 2026 | -69.2 | Simply Wall St |
5 years to Oct 2026 | -87.9 | Simply Wall St |
Since listing | ~-99.9 | Simply Wall St |
Market Valuation
| Metric | FY2025 | Jan2026 | Aug2026 | Oct2026 |
|---|---|---|---|---|
Market cap approx (AUD Mn) | 20 | 30 | 12 | 14 |
Valuation Snapshot
| Multiple | Value | Comment |
|---|---|---|
P/E | n/m | Loss-making |
EV/EBITDA | n/m | Negative EBITDA |
EV/Sales | n/m | Revenue ~nil (S&P P/S ~860x is not meaningful) |
P/B | ~2.4x | ~A$13.4m market cap / A$5.57m net assets at Dec 2025 (book value has since changed; indicative only) |
Capital Markets
| Item | Status |
|---|---|
Analyst consensus | None — 0 analysts (Simply Wall St) |
Dividend history | Never paid |
Dividend policy | None (exploration/development stage) |
Credit ratings (Moody's / S&P / Fitch) | Not rated |
Debt maturity profile | No borrowings after Feb 2026 loan repayment (to the extent disclosed) |
Analyst Conclusions
Management guidance
First antimony concentrate from Tecomatlán in 2H CY2026 via a production-capable proof-of-concept campaign on ~200 t of high-grade ore; staged commissioning toward 150 tpd; maiden Los Lirios JORC resource in Q4 CY2026; pursuit of strategic/offtake partners and US non-dilutive funding. No financial guidance.
Consensus expectations
None — no sell-side coverage.
Bull case
-
First concentrate de-risks the model. With crushing underway, 200 t crushed at an estimated ~12.6% Sb, and flotation demonstrated at 81% recovery, a saleable 40–60%+ Sb concentrate in late 2026 would transform ANT from explorer to producer at a ~A$14m valuation.
-
Scalable feed network. A binding five-year Chinantla agreement plus Vinatas and other MOUs (>50% of nameplate) could support continuous throughput, with Los Lirios later adding proprietary feed.
-
Policy tailwinds. Western critical-minerals programmes and offtaker demand for non-Chinese antimony could unlock prepayment, offtake or government funding (Wogen/XCLR concept; MineMaker engagement).
Bear case
-
Funding treadmill. A going-concern uncertainty, ~A$5.5m cash burn in H1 FY2026 (including non-cash items), and a small A$1.52m rights issue imply further dilution before meaningful cash flow.
-
Execution slippage. The JORC target slipped a quarter, the gravity flowsheet underperformed, and the plant timeline has been described as 10–12 months from July 2026 — risk that "first concentrate" is a small test parcel rather than sustained production.
-
Price and feed fragility. Antimony prices have retreated from 2025 peaks; reliance on artisanal third-party ore exposes margins and continuity, and the 150 tpd scale limits operating leverage.
Catalysts and monitorables (next 12 months)
| Catalyst | Expected timing | What to watch |
|---|---|---|
| FY2026 Annual Report and audit opinion | Late Sep–Oct 2026 | Going-concern wording; cash at 30 Jun 2026 |
| September quarter report | ~26 Oct 2026 | Cash runway; commissioning progress |
| Wet commissioning and first concentrate | 2H CY2026 | Recovery, grade, tonnes produced |
| First concentrate sale / binding offtake | Late 2026–2027 | Counterparty, pricing, prepayment |
| Maiden Los Lirios JORC resource | Q4 CY2026 | Tonnes/grade vs Exploration Target |
| Yanamina sale completion | Not dated | Receipt of US$6m staged consideration |
| Tecomatlán purchase-option decision | Tied to permitting | Capital commitment |
| Permanent CEO appointment | Not dated | Management depth |
| CFE grid connection | Not dated | Operating cost reduction |
| Nevada field programmes | 2026–2027 | Drill-target definition at Dollar/Milton |
Analyst verdict
Antimony Resources Limited is the latest incarnation of a 1985-vintage ASX shell that has repeatedly reinvented itself — most recently as Jadar Resources, then EV Resources, and since 21 September 2026, Antimony Resources. The 2025–2026 antimony strategy is the most coherent the company has articulated in years: rather than waiting for a greenfield mine, management secured an existing 150 tpd mill in Puebla on deferred, milestone-based terms, proved a flotation flowsheet capable of 81% recovery and 42–68% Sb concentrates on regional ores, and locked in a binding five-year third-party feed contract. That is genuine progress, and it aligns with a real market dislocation in Western antimony supply.
However, the investment case remains speculative and binary. The company is pre-revenue, has no JORC resource, carries an auditor-flagged going-concern uncertainty, and has funded itself through dilution severe enough to require a 10:1 consolidation. Its July 2026 capital raise was small (A$1.52m) and coincided with the departure of its MD/CEO, leaving an Executive Chairman and an Interim CEO to deliver commissioning. Share-price performance (roughly -71% over one year and -88% over five years to October 2026) reflects market scepticism, and antimony prices have softened from their 2025 highs.
The near-term determinant of value is simple: can Tecomatlán produce and sell a meaningful tonnage of saleable concentrate in late 2026 or early 2027, at a margin, with reliable third-party feed? Success would justify a material re-rating given the ~A$14 million market capitalisation and could unlock offtake or government-linked funding. Failure or prolonged delay would likely mean further heavy dilution. Investors should treat ANT as a high-risk, catalyst-driven micro-cap, sized accordingly, and monitor the FY2026 audit opinion, the September-quarter cash position, first-concentrate metrics, and the maiden Los Lirios resource as the key decision points.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Tenure / dates | Background (as disclosed) |
|---|---|---|---|
Shane Menere | Executive Chairman (from Jul 2026); Non-Executive Chairman Jun 2025–Jul 2026 | Appointed Jun 2025 | Appointed to drive commercialisation of antimony assets; prior roles not detailed in sources reviewed |
Miguel Barahona | Interim CEO (from Jul 2026); previously President of Mexican Operations | Appointed during H1 FY2026 | Mining engineer with track record of bringing small-to-medium mines into production in Mexico |
Adrian Paul | Executive Director | Long-serving (Jadar era) | — |
Luke Martino | Non-Executive Director | Long-serving | — |
Justin Werner | Non-Executive Director | Appointed Jun 2025 | Not detailed in sources reviewed |
Tim Young | Non-Executive Director | — | Company spokesperson on rebrand (Sep 2026) |
Louisa Martino | Company Secretary | Long-serving | B.Com, CA |
Michael (Mike) Brown | Former MD & CEO | 16 Oct 2025 – Jul 2026 | MAIG; acted as Competent Person for exploration and metallurgy disclosures |
Hugh Callaghan | Former Managing Director/Executive Director | Resigned 24 Aug 2025 | — |
Directors' Remuneration
| Director compensation component (AUD Mn) | H1FY2025 | H1FY2026 |
|---|---|---|
Director fees (cash) | 0.274 | 0.235 |
Director share-based payments | -0.217 | 1.513 |
Board & Management Changes
| Date | Change | Context |
|---|---|---|
Jun 2025 | Shane Menere (NE Chair) and Justin Werner (NED) appointed | Antimony commercialisation focus |
24 Aug 2025 | Hugh Callaghan resigned | Strategy transition |
16 Oct 2025 | Mike Brown appointed MD & CEO | Lead North American antimony strategy |
20 Jul 2026 | Brown steps down; Menere Executive Chairman; Barahona Interim CEO | Announced with rights issue and consolidation |
By Sep 2026 | Tim Young NED | Rebrand to Antimony Resources |
Competitive Landscape
Key Competitors
| Company | Listing | Asset / segment | Stage | Relative positioning vs ANT |
|---|---|---|---|---|
United States Antimony Corp | NYSE American: UAMY | US/Mexico antimony processing and smelting | Producer | Established processor in Mexico; potential competitor for artisanal feed and potential customer |
Perpetua Resources | Nasdaq/TSX: PPTA | Stibnite gold-antimony (Idaho) | Development | Far larger, US-government-backed; long-dated |
Mandalay Resources | TSX: MND | Costerfield gold-antimony (Victoria) | Producer | Established Western antimony producer |
Larvotto Resources | ASX: LRV | Hillgrove antimony-gold (NSW) | Development | Larger ASX antimony developer |
Nova Minerals | ASX: NVA | Estelle antimony-gold (Alaska) | Exploration/development | US-government engagement on antimony |
Felix Gold | ASX: FXG | Alaska antimony stockpiling/processing | Early processing | Similar "near-term processing" narrative |
Red Mountain Mining | ASX: RMX | Silver Dollar antimony (Idaho) | Exploration | Peer in US antimony exploration |
Trigg Minerals | ASX: TMG | US/Australian antimony incl. Coyote Creek | Exploration | Bought ANT's Coyote Creek |
Military Metals Corp | CSE: MILI | Last Chance (Nevada), Trojarová (Slovakia) | Exploration | Nevada neighbour (~9 km from Dollar) |
Locksley Resources | ASX: LKY | Desert Antimony (California) | Exploration | US antimony peer |
Competitive Advantages & Vulnerabilities
| Advantages | Vulnerabilities |
|---|---|
Control of an existing mill reduces time-to-first-concentrate vs greenfield peers | Plant is small (150 tpd) and not yet wet-commissioned at full flowsheet |
Binding third-party feed (Chinantla) close to plant (~8 km) | Dependence on artisanal/small-scale third-party feed (quality, continuity, ESG) |
High-grade surface mineralisation at Los Lirios | No JORC resource; timeline slips |
Mexico/US positioning aligned with Western supply-security policy | Micro-cap balance sheet; repeated dilution |
Demonstrated concentrate grades (42–68% Sb) in testwork | Limited management depth after CEO departure |
Peer Comparison FY2025
| Metric | Antimony Resources | Larvotto Resources | Perpetua Resources | Mandalay Resources |
|---|---|---|---|---|
Stage | Pre-production processor | Developer | Developer | Producer |
Market cap | ~A$13–14m | — | — | — |
Recent Developments
--



